|
More site info...
Articles of Interest | Forum profile
|
|
Forum profile page for Articles of Interest on http://her2support.org.
This report page is the aggregated overview from a single forum: Articles of Interest, located on the Message Board at http://her2support.org.
This forum profile page summarizes the general forum statistics such as: Users Activity, Forum Activity, and Top Authors, which are reported in either a table or graph below for a given reporting time period.
Additional forum profile information for "Articles of Interest" on the Message Board at http://her2support.org is also shown in the following ways:
1) Latest Active Threads
2) Hot Threads for Last Week
Warning: These statistics are generated using 'best efforts' and can experience delays and reporting errors at times. Please note that such statistics do not constitute a forum's popularity and/or exact posting volumes at any given reporting period.
|
|
|
|
|
Posting activity on Articles of Interest:
|
|
Week
|
Month
|
3 Months
|
|
Threads:
|
64
|
127
|
259
|
|
Post:
|
105
|
205
|
371
|
|
|
Articles of Interest Posting activity graph:
|
Top authors during last week:
user's latest post:
Herceptin (Traztuzumab)
Published (2009-11-08 13:38:00)
This article is a description of how Herceptin works. Hopefully it is helping you. It says even if it doesn't stop your cancer 100%, it should be continued, maybe with the addition of Lapatinib (Tykerb) or other chemotherapies.
user's latest post:
Repeat FISH Testing of Breast...
Published (2009-11-06 07:18:00)
This is a Medscape Article, and may require registration (free) to access: http://www.medscape.com/viewarticle/711865 Her2support's registration info: Username: Her2support Password: Member Hopeful
user's latest post:
Kanzius "machine"...
Published (2009-11-03 08:20:00)
I saw this on 60 Minutes. It was very exciting to me. Mr. John Kanzius was an inspiration. This could truly be a breakthrough that we have all been waiting for. Just think, one could be cured and not have to go through all the surgery, chemo effects, etc. that everyone on this board has endured.
user's latest post:
GM-CSF as therapy
Published (2009-11-07 14:18:00)
I did tons of research prior to therapy. My onc was going to do Neulasta but said he would do Leukine without hesitation. I used Leukine after all cycles, including my 4 AC treatments and the Taxol treatments. Normally, Neulasta is not given after the last chemo (since you have all the time in the world to recover). But I got 7 daily injections of Leukine to re-boost the good stuff as my onc said that is why it is done. It takes Leukine...
user's latest post:
Melatonin cancer treatment...
Published (2009-10-31 22:57:00)
I have a theory on my cancer. I developed characteristics of autism when I was in kindergarten. Autistism shares similar characteristics to mercury poisoning. They say autistics are low in melatonin. Perhaps this is the beginning of the cancer disease chain. The common link in "advanced" countries being the increased vaccination rates with thimerosol as a preservative. Autistics are more likely to have allergies, asthma, selective...
user's latest post:
preclinical: metronomic...
Published (2009-11-01 02:29:00)
Yes, I just heard Dr. Kerbel speak on a similar protocol at the San Diego conference I attended mid-October. Among what he discussed: Clin Cancer Res. 2009 Oct 15;15(20):6358-66. Epub 2009 Oct 13. Comparative impact of trastuzumab and cyclophosphamide on HER-2-positive human breast cancer xenografts. Francia G, Man S, Lee CJ, Lee CR, Xu P, Mossoba ME, Emmenegger U, Medin JA, Kerbel RS. Molecular and Cellular Biology Research, Sunnybrook Health...
user's latest post:
The HER2 and HER3 Interaction
Published (2009-11-02 17:47:00)
UCSF is doing some cutting edge research regarding the role between the HER2 and HER3 proteins and the interactions between the two. According to the article on page 3 of the Fall Newsletter (link below), HER2 cannot cause breast cancer without the help of HER3 and research at UCSF is re-defining the causative driver of this disease as the HER2-HER3 dimer, not just HER2. This is why I am SO excited about targeted therapies like Neratinib,...
user's latest post:
Small, node-negative...
Published (2009-11-04 13:27:00)
http://www.nlm.nih.gov/medlineplus/n...ory_91392.html The story doesn't give stats, just a comparison between her2-positive and -negative.
user's latest post:
Lapatinib: A competitor or...
Published (2009-11-05 22:06:00)
This is combo I did but mine was for newly diagnosed Stage II or III, cancer could not have spread to get in the trial. As you can see below, my results were amazing. It totally did away with my tumor. I hope this will make it easier for all to get this combo.
user's latest post:
Cannabinoids and cancer
Published (2009-11-08 14:01:00)
Thanks Rich I have a Canadian friend who believes a relative of hers was cured of advanced cancer by taking cannabis oil brewed in her own kitchen from the heads of the hemp plant. I was sceptical at first but who knows!! Ellie
|
|
|
|
Latest active threads on Articles of Interest::
Started 4 months, 2 weeks ago (2009-06-23 12:16:00)
by Rich66
Cannabinoids and cancer
1: Cancer Lett. 2009 May 11. [Epub ahead of print] Links
Cannabinoids in the treatment of cancer.
Alexander A , Smith PF , Rosengren RJ .
Department of Pharmacology and Toxicology, University of Otago, Dunedin 9001, New Zealand.
Cannabinoids, the active components of the hemp plant ...
Started 1 day, 21 hours ago (2009-11-08 13:28:00)
by cynthia1962
hello rich
in plan english what does this means. because I read the posting everyday day. This is what I am taking every three weeks does this trastuzumab leads to tumors. Because my mri states deep white matters due to early small vessel desease or chemotherapy. I am going to a neurologist on 11/19 because I am afraid I may have some type of tumor in my brain.
Started 6 months, 3 weeks ago (2009-04-16 18:38:00)
by eric
Since I've read about cancer stem cells I've felt that killing them is the
key to curing or managing the disease.
Started 2 days, 9 hours ago (2009-11-08 02:07:00)
by Rich66
PATENT: Ok...2002 filing, 2009 publication???? At least suggestion the researcher lives..maybe. Anyone live in Pikesville, Maryland?
http://www.freepatentsonline.com/7547673.html
Title:
Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of ATP production...
Started 2 days, 10 hours ago (2009-11-08 00:37:00)
by Rich66
Above is the full 22 page PDF.
Breast Cancer Res. 2009 Nov 5;11(6):R79. [Epub ahead of print]
Hes-6, an inhibitor of Hes-1, is regulated by 17beta-estradiol and promotes breast cancer cell proliferation.
Hartman J , Lam EW , Gustafsson JA , Strom A .
ABSTRACT: INTRODUCTION: Hes-6 is a member of the basic-helix-loop-helix (bHLH) family of transcription ...
Started 2 days, 23 hours ago (2009-11-07 11:58:00)
by Becky
Nice finds as the first two studies I have not seen. I used GM-CSF (brand name Leukine) instead of Neulasta as my white cell booster taking it days 2-12 after every chemo cycle and for 2-9 after my last chemo cycle.
Who knows why I continue to do well? I pulled out all the stops at the time because Herceptin was not available in the adjuvant setting at the time (even though I got it starting ...
Started 3 days, 11 hours ago (2009-11-06 23:41:00)
by Rich66
How Eating Fruit and Vegetables Can Improve Cancer Patients’ Response to Chemotherapy
UC Riverside study describes how naturally occurring apigenin facilitates the death of cancer cells
(October 22, 2008)
NEWS MEDIA CONTACT
Name: Iqbal Pittalwala
Tel: (951) 827-6050
E-mail: iqbal@ucr.edu
...
Started 6 months ago (2009-05-12 14:30:00)
by Soccermom2006
Genes found to play a role in breast cancer's spread to the brain
http://www.eurekalert.org/pub_releas...-gft050109. php
"New research led by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) identifies three genes that specifically mediate the metastasis, or spread, of breast cancer to the brain and illuminates the ...
Started 3 days, 14 hours ago (2009-11-06 20:44:00)
by Rich66
Cancer Cell. 2009 Jan 6;15(1):35-44.
Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche.
Erler JT , Bennewith KL , Cox TR , Lang G , Bird D , Koong A , Le QT , Giaccia AJ .
Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Tumor cell metastasis is facilitated by "...
|
|
Hot threads for last week on Articles of Interest::
Started 6 days, 16 hours ago (2009-11-03 18:21:00)
by Rich66
Int J Oncol. 2007 Feb;30(2):509-20.
Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer.
Osipo C , Meeke K , Cheng D , Weichel A , Bertucci A , Liu H , Jordan VC .
Department of Pathology, Oncology Institute, Cardinal Bernadin Cancer Center, Loyola University Medical Center, Maywood, IL, USA.
Tamoxifen resistance is common for estrogen receptor alpha (ERalpha) ...
Started 5 days, 9 hours ago (2009-11-05 01:33:00)
by Rich66
Rexin-G: Tumor-Targeted Injectable Genetic Medicine
http://www.epeiusbiotech.com/
Rexin-G ® - Tumor-Targeted Injectable Genetic Medicine
About Rexin-G ®
Scientists at Epeius Biotechnologies have developed the high-technologies that can deliver a new class of powerful biological ...
Started 1 week ago (2009-11-03 08:10:00)
by Hopeful
CBS 60 Minutes did an update on the machine 2 weeks ago. The entire episode is available for viewing on their website: http://www.cbsnews.com/video/watch/?...inColumnAre a.2
Hopeful
Started 5 days, 15 hours ago (2009-11-04 19:21:00)
by Rich66
J Cancer Res Clin Oncol. 2009 Apr;135(4):643-7. Epub 2008 Oct 21.
Monitoring circulating epithelial tumour cells (CETC) to gauge therapy: in patients with disease progression after trastuzumab persisting CETC can be eliminated by combined lapatinib treatment.
Camara O , Jörke C , Hammer U , Egbe A , Rabenstein C , Runnebaum IB , Hoeffken K , Pachmann K .
Women's Hospital, ...
Started 2 days, 9 hours ago (2009-11-08 02:07:00)
by Rich66
PATENT: Ok...2002 filing, 2009 publication???? At least suggestion the researcher lives..maybe. Anyone live in Pikesville, Maryland?
http://www.freepatentsonline.com/7547673.html
Title:
Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of ATP production...
Started 1 day, 21 hours ago (2009-11-08 13:28:00)
by cynthia1962
hello rich
in plan english what does this means. because I read the posting everyday day. This is what I am taking every three weeks does this trastuzumab leads to tumors. Because my mri states deep white matters due to early small vessel desease or chemotherapy. I am going to a neurologist on 11/19 because I am afraid I may have some type of tumor in my brain.
Started 2 days, 23 hours ago (2009-11-07 11:58:00)
by Becky
Nice finds as the first two studies I have not seen. I used GM-CSF (brand name Leukine) instead of Neulasta as my white cell booster taking it days 2-12 after every chemo cycle and for 2-9 after my last chemo cycle.
Who knows why I continue to do well? I pulled out all the stops at the time because Herceptin was not available in the adjuvant setting at the time (even though I got it starting ...
Started 1 month ago (2009-10-08 06:42:00)
by Hopeful
Interesting Review of Tamoxifen vs. AI study results
http://www.nature.com/bjc/journal/v1.../6605231a.h tml
Hopeful
Started 1 week ago (2009-11-02 17:56:00)
by Rich66
direct link (scroll to p.3)
http://www.ucsfbreastcarecenter.org/aboutindex5.ht mlT
the contents:
HER2 and the Power of Translational Research: Part II
Continued from the BCC Newsletter, Spring, 2009
BREAST CARE CENTER NEWSLETTER • fall 2009 3
While it had been thought for many
years that the activating partner for
HER2 could be another HER2 protein,
our laboratory research group...
Started 3 days, 14 hours ago (2009-11-06 20:44:00)
by Rich66
Cancer Cell. 2009 Jan 6;15(1):35-44.
Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche.
Erler JT , Bennewith KL , Cox TR , Lang G , Bird D , Koong A , Le QT , Giaccia AJ .
Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Tumor cell metastasis is facilitated by "...
|
|